Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 June;58(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 June;58(2):224-33

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 June;58(2):224-33

    ORIGINAL ARTICLES

Synthesis and biological evaluation of 177Lu-DOTA-porphyrin conjugate: a potential agent for targeted tumor radiotherapy

Bhadwal M. 1, Mittal S. 1, Das T. 1, Sarma H. D. 2, Chakraborty S. 1, Banerjee S. 1, Pillai M. R. 1

1 Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai India;
2 Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai India

A novel unsymmetrically substituted water soluble porphyrin derivative namely, 5-(p-amino­propylene­­oxyphenyl)-10,15,20-tris-(p-carboxy­methyl­ene­oxyphenyl)porphyrin was synthesized and coupled with a bifunctional chelating agent, viz. p-NCS-benzyl-DOTA (p-isothiocyanatobenzyl-1,4,7,10-tetra­aza­cyclodo­decane-1,4,7,10-tetra­acetic acid) for developing a suitable conjugate for use in targeted tumor therapy. The porphyrin-p-NCS-benzyl-DOTA conjugate was radiolabeled with 177Lu in good radiolabeling yield. Biodistribution studies performed in Swiss mice bearing fibrosarcoma tumors revealed high tumor uptake (5.33±1.11% injected activity per gm of tumor) within 30 min post-injection. The complex exhibited favorable tumor to blood and tumor to muscle ratios at various post-administration time points. Fast clearance of the non-accumulated activity was observed mostly through the renal pathway. Scintigraphic imaging studies performed in Swiss mice bearing fibrosarcoma tumors also exhibited selective accumulation of activity in the tumor.

language: English


FULL TEXT  REPRINTS

top of page